Eurobio Scientific Société anonyme (EPA:ALERS)

EPA:ALERS Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	45.12	49.3	47.49	92.92	65.1	7.02
Short-Term Investments	41.47	39.73	38.44	9.47	0.46	0.6
Cash & Short-Term Investments	86.59	89.03	85.94	102.39	65.56	7.62
Cash Growth	22.39%	3.60%	-16.07%	56.18%	760.44%	-30.77%
Accounts Receivable	27.82	26.94	32.78	43.86	51.21	18.64
Other Receivables	5.53	3.74	6.09	8.32	5.52	2.76
Receivables	33.35	30.67	38.87	52.18	56.73	21.4
Inventory	23.43	21.45	21.65	16.29	12.93	8.89
Prepaid Expenses	1.28	1.01	0.57	0.47	-	0.47
Other Current Assets	1.64	1.39	1.53	2.27	-	0.36
Total Current Assets	146.67	143.91	148.69	173.6	135.21	40.32
Property, Plant & Equipment	11.61	12.3	12.66	10.05	9.92	7.75
Long-Term Investments	3.91	3.6	3.6	3.6	0	0
Goodwill	117.7	117.71	115.81	18.19	20.93	22.54
Other Intangible Assets	1.95	2.52	1.97	2.29	3.84	5.86
Long-Term Deferred Tax Assets	-	-	-	-	-	1.54
Long-Term Deferred Charges	30.75	32.9	37.2	1.28	1.66	1.71
Other Long-Term Assets	0	-	-	0	0	0.7
Total Assets	313.77	316.33	330.73	209.87	172.3	81.01
Accounts Payable	19.12	16.82	18.53	16.77	14.24	10.89
Accrued Expenses	5.17	6.07	9.63	6.57	5.21	3.02
Current Portion of Long-Term Debt	13.61	13.28	13.73	3.68	13.94	7.37
Current Portion of Leases	1.8	1.8	1.6	1.56	1.5	1.1
Current Income Taxes Payable	4.14	3.56	1.97	6.28	11.54	1.51
Current Unearned Revenue	0.28	0.2	0.44	0.16	0.18	0.15
Other Current Liabilities	2.44	2.64	1.25	1.05	1.39	7.77
Total Current Liabilities	54.55	52.88	57.32	36.11	47.98	31.8
Long-Term Debt	74.56	81.23	94.34	7.01	10.97	7.73
Long-Term Leases	3.44	4.35	3.97	3.44	3.31	3.06
Other Long-Term Liabilities	1.83	2.17	1.53	1.69	1.38	1.18
Total Liabilities	134.94	141.16	157.75	49	64.45	44.44
Common Stock	3.28	3.5	3.63	3.63	3.63	3.6
Additional Paid-In Capital	20.19	33.57	40.05	40.05	40.05	156.2
Comprehensive Income & Other	155.35	138.1	129.31	117.19	64.17	-123.23
Total Common Equity	178.83	175.17	172.98	160.87	107.85	36.56
Shareholders' Equity	178.83	175.17	172.98	160.87	107.85	36.56
Total Liabilities & Equity	313.77	316.33	330.73	209.87	172.3	81.01
Total Debt	93.4	100.66	113.64	15.69	29.72	19.26
Net Cash (Debt)	-6.81	-11.63	-27.7	86.7	35.84	-11.64
Net Cash Growth	-	-	-	141.89%	-	-
Net Cash Per Share	-0.61	-1.04	-2.44	7.97	3.18	-1.04
Filing Date Shares Outstanding	10.03	10.04	10.22	10.85	11.21	11.21
Total Common Shares Outstanding	10.03	10.04	10.22	10.85	11.21	11.21
Working Capital	92.13	91.03	91.37	137.49	87.23	8.52
Book Value Per Share	17.83	17.44	16.92	14.83	9.62	3.26
Tangible Book Value	59.18	54.94	55.21	140.39	83.08	8.16
Tangible Book Value Per Share	5.90	5.47	5.40	12.94	7.41	0.73
Buildings	1.82	1.33	0.88	0.85	0.71	0.52
Machinery	2.26	0.76	1.12	1.12	8.5	6.99
Construction In Progress	-	0.48	0.45	0.01	1.21	1.59

Source: S&P Global Market Intelligence. Standard template. Financial Sources.